BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ji D, Liu Y, Si LL, Li L, Chen GF, Xin SJ, Zhao JM, Xu D. Variable influence of mutational patterns in reverse-transcriptase domain on replication capacity of hepatitis B virus isolates from antiviral-experienced patients. Clin Chim Acta. 2011;412:305-313. [PMID: 21056552 DOI: 10.1016/j.cca.2010.10.028] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Ge FL, Si LL, Yang Y, Li YH, Lv ZL, Liu WH, Liao H, Wang J, Zou J, Li L, Li H, Zhang ZL, Wang JB, Lu XC, Xu DP, Bai ZF, Liu Y, Xiao XH. Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Suppressed HBV Replication in Mouse Model. Front Pharmacol 2021;12:756975. [PMID: 34776974 DOI: 10.3389/fphar.2021.756975] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Ababneh NA, Sallam M, Kaddomi D, Attili AM, Bsisu I, Khamees N, Khatib A, Mahafzah A. Patterns of hepatitis B virus S gene escape mutants and reverse transcriptase mutations among genotype D isolates in Jordan. PeerJ 2019;7:e6583. [PMID: 30867996 DOI: 10.7717/peerj.6583] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
3 Liu Y, Yao W, Si L, Hou J, Wang J, Xu Z, Li W, Chen J, Li R, Li P, Bo L, Xiao X, Lan J, Xu D. Chinese herbal extract Su-duxing had potent inhibitory effects on both wild-type and entecavir-resistant hepatitis B virus (HBV) in vitro and effectively suppressed HBV replication in mouse model. Antiviral Res 2018;155:39-47. [PMID: 29702120 DOI: 10.1016/j.antiviral.2018.04.017] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
4 Zang H, Xu Z, Liu Y, Li X, Rong Y, Jiang L, You S, Hu J, Zhao J, Xu D, Xin S. Clinical and virological implications of A1846T and C1913A/G mutations of hepatitis B virus genome in severe liver diseases. Scand J Gastroenterol 2018;53:319-28. [PMID: 29322851 DOI: 10.1080/00365521.2018.1424934] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
5 Zhang K, Liu Y, Chen R, Li Q, Xu Z, Si L, Cheng Y, Yang Y, Chen J, Xu D, Lin S. Antigenicity reduction contributes mostly to poor detectability of HBsAg by hepatitis B virus (HBV) S-gene mutants isolated from individuals with occult HBV infection. J Med Virol. 2018;90:263-270. [PMID: 28876463 DOI: 10.1002/jmv.24936] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
6 Xu X, Xiang K, Su M, Li Y, Ji W, Li Y, Zhuang H, Li T. HBV Drug Resistance Substitutions Existed before the Clinical Approval of Nucleos(t)ide Analogues: A Bioinformatic Analysis by GenBank Data Mining. Viruses 2017;9:E199. [PMID: 28749433 DOI: 10.3390/v9080199] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
7 Liao H, Li X, Liu Y, Xu Z, Huang P, Nian X, Liu X, Xu D. Intergenotype recombinant analysis of full-length hepatitis B virus genomes from 516 Chinese patients with different illness categories. J Med Virol. 2016; Jun 22. [Epub ahead of print]. [PMID: 27328656 DOI: 10.1002/jmv.24609] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
8 Li X, Qin Y, Liu Y, Li F, Liao H, Lu S, Qiao Y, Xu D, Li J. PreS deletion profiles of hepatitis B virus (HBV) are associated with clinical presentations of chronic HBV infection. J Clin Virol 2016;82:27-32. [PMID: 27415434 DOI: 10.1016/j.jcv.2016.06.018] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
9 Caligiuri P, Cerruti R, Icardi G, Bruzzone B. Overview of hepatitis B virus mutations and their implications in the management of infection. World J Gastroenterol 2016; 22(1): 145-154 [PMID: 26755866 DOI: 10.3748/wjg.v22.i1.145] [Cited by in CrossRef: 92] [Cited by in F6Publishing: 96] [Article Influence: 15.3] [Reference Citation Analysis]
10 Su H, Liu Y, Xu Z, Cheng S, Ye H, Xu Q, Liu Q, Tan S, Xu D, Liu Y. A novel complex A/C/G intergenotypic recombinant of hepatitis B virus isolated in southern China. PLoS One 2014;9:e84005. [PMID: 24475029 DOI: 10.1371/journal.pone.0084005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
11 Ji D, Liu Y, Li L, Xu Z, Si LL, Dai JZ, Li X, Wang L, Yao Z, Xin SJ. The rtL229 substitutions in the reverse transcriptase region of hepatitis B virus (HBV) polymerase are potentially associated with lamivudine resistance as a compensatory mutation. J Clin Virol. 2012;54:66-72. [PMID: 22398037 DOI: 10.1016/j.jcv.2012.02.003] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.1] [Reference Citation Analysis]
12 Zhong Y, Han J, Zou Z, Liu S, Tang B, Ren X, Li X, Zhao Y, Liu Y, Zhou D. Quantitation of HBV covalently closed circular DNA in micro formalin fixed paraffin-embedded liver tissue using rolling circle amplification in combination with real-time PCR. Clin Chim Acta. 2011;412:1905-1911. [PMID: 21741960 DOI: 10.1016/j.cca.2011.06.031] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 2.7] [Reference Citation Analysis]